Emerging clinical evidence suggests that CXCL8/CXCR1/2 signal axis plays a key role in immune escape and CXCL8 high expressed colon cancer seldom benefit from ICIs therapy [14,15]. This evidence concerns the gene CXCR1 and malignant colon neoplasm.